Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression

被引:15
|
作者
Bailey, Peter [1 ,2 ,3 ]
Ridgway, Rachel A. [4 ]
Cammareri, Patrizia [4 ,12 ]
Treanor-Taylor, Mairi [4 ,5 ]
Bailey, Ulla-Maja [4 ]
Schoenherr, Christina [4 ]
Bone, Max [1 ,4 ]
Schreyer, Daniel [1 ]
Purdie, Karin [6 ]
Thomson, Jason [6 ,7 ]
Rickaby, William [8 ]
Jackstadt, Rene [4 ,13 ]
Campbell, Andrew D. [4 ]
Dimonitsas, Emmanouil [9 ]
Stratigos, Alexander J. [9 ]
Arron, Sarah T. [10 ]
Wang, Jun [6 ]
Blyth, Karen [1 ,4 ]
Proby, Charlotte M. [11 ]
Harwood, Catherine A. [6 ,7 ]
Sansom, Owen J. [1 ,4 ]
Leigh, Irene M. [6 ]
Inman, Gareth J. [1 ,4 ]
机构
[1] Univ Glasgow, Sch Canc Sci, Glasgow City G61 1QH, Scotland
[2] Heidelberg Univ, Dept Surg, D-69120 Heidelberg, Germany
[3] Univ Clin Heidelberg, Sect Surg Res, D-69120 Heidelberg, Germany
[4] Canc Res UK Beatson Inst, Glasgow City G61 1BD, Scotland
[5] Univ Edinburgh, Edinburgh Med Sch, Edinburgh EH16 4TJ, Scotland
[6] Queen Mary Univ London, Fac Med & Dent, London E1 1BB, England
[7] Royal London Hosp, Dept Dermatol, Barts Hlth NHS Trust, London E1 1BB, England
[8] St Thomas Hosp, St Johns Inst Dermatol, London SE1 7EP, England
[9] Natl & Kapodistrian Univ Athens, Andreas Sygros Hosp, Med Sch, Dept Dermatol & Venereol 1, Athens 16121, Greece
[10] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA USA
[11] Univ Dundee, Sch Med, Mol & Clin Med, Dundee DD1 4HN, Scotland
[12] Univ Edinburgh, Inst Genet & Canc, Canc Res UK Scotland Ctr, Edinburgh EH4 2XR, Scotland
[13] German Canc Res Ctr, D-61920 Heidelberg, Germany
关键词
PROGENITOR STATE; DIFFERENTIATION; EXPRESSION; SIGNATURES; TARGET; KLF4;
D O I
10.1038/s41467-023-40822-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The molecular basis of disease progression from UV-induced precancerous actinic keratosis (AK) to malignant invasive cutaneous squamous cell carcinoma (cSCC) and potentially lethal metastatic disease remains unclear. DNA sequencing studies have revealed a massive mutational burden but have yet to illuminate mechanisms of disease progression. Here we perform RNAseq transcriptomic profiling of 110 patient samples representing normal sun-exposed skin, AK, primary and metastatic cSCC and reveal a disease continuum from a differentiated to a progenitor-like state. This is accompanied by the orchestrated suppression of master regulators of epidermal differentiation, dynamic modulation of the epidermal differentiation complex, remodelling of the immune landscape and an increase in the preponderance of tumour specific keratinocytes. Comparative systems analysis of human cSCC coupled with the generation of genetically engineered murine models reveal that combinatorial sequential inactivation of the tumour suppressor genes Tgfbr2, Trp53, and Notch1 coupled with activation of Ras signalling progressively drives cSCC progression along a differentiated to progenitor axis. Taken together we provide a comprehensive map of the cSCC disease continuum and reveal potentially actionable events that promote and accompany disease progression.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Cutaneous Squamous Cell Carcinoma: Genomic Progression from Precancerous Lesions
    Lorenz, Judith
    AKTUELLE DERMATOLOGIE, 2022, 48 (06) : 248 - 248
  • [32] Ephrin-A loss in cutaneous squamous cell carcinoma progression and metastasis
    Zheng, J.
    White, B. Perez
    Kaplan, N.
    Petty, A.
    Zhao, Z.
    Honda, K.
    Denning, M.
    Blumenberg, M.
    Getsios, S.
    Wang, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S14 - S14
  • [33] Cutaneous squamous cell carcinoma and the PARK2 gene
    Inzelberg, R.
    Friedman, E.
    Azizi, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (01) : 323 - 324
  • [34] Cutaneous squamous cell carcinoma
    Leiter, U.
    Gutzmer, R.
    Alter, M.
    Ulrich, C.
    Meiwes, A.
    Heppt, M., V
    Steeb, T.
    Berking, C.
    Lonsdorf, A. S.
    Sachse, M. M.
    Garbe, C.
    Hillen, U.
    HAUTARZT, 2020, 71 (08): : 597 - 606
  • [35] Cutaneous squamous cell carcinoma
    Leiter, Ulrike
    Gutzmer, Ralf
    Alter, Mareike
    Ulrich, Claas
    Lonsdorf, Anke S.
    Sachse, MichaelM.
    Hillen, Uwe
    ONKOLOGE, 2017, 23 (06): : 479 - 491
  • [36] Cutaneous squamous cell carcinoma
    Meiwes, Andreas
    Leiter, Ulrike
    ONKOLOGE, 2019, 25 (09): : 831 - 843
  • [37] Cutaneous Squamous Cell Carcinoma
    Parekh, Vishwas
    Seykora, John T.
    CLINICS IN LABORATORY MEDICINE, 2017, 37 (03) : 503 - +
  • [38] Cutaneous Squamous Cell Carcinoma
    Waldman, Abigail
    Schmults, Chrysalyne
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 33 (01) : 1 - +
  • [39] Cutaneous Squamous Cell Carcinoma
    Leiter, U.
    Gutzmer, R.
    Alter, M.
    Ulrich, C.
    Lonsdorf, A. S.
    Sachse, M. M.
    Hillen, U.
    HAUTARZT, 2016, 67 (11): : 857 - 866
  • [40] JunB activity is lost during cutaneous squamous cell carcinoma progression.
    Crawford, HC
    Matrisian, LM
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 2708 - 2708